BMRN
BioMarin Pharmaceutical Inc.
November 2, 2026 · after-hours
- Rarity
- 2.04
- Peak move
- −6.72%
- Float cap
- $10.9B
Still running — rarity and peak move can only rise from here.
BioMarin Pharmaceutical Inc. is a global rare disease biotechnology company that develops and commercializes therapies for genetically defined conditions. Its commercial products include VOXZOGO for achondroplasia, enzyme replacement therapies for mucopolysaccharidoses, and PALYNZIQ for phenylketonuria. The company serves patients with rare genetic diseases worldwide.
Where do you see this going?
no votes yetVote to see the split.
What we found
no events · 0 from SEC or newswire · 0 timed with the moveNothing found.We searched SEC filings, the newswires and the open web across the three days around this move and found no public information that explains it.